Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study-Reference-Cited by-同舟云学术

Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study

Published:2024-05 Issue: Volume:202 Page:107339
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Delanty Norman,Mohanraj Rajiv,Shankar Rohit,Wehner Tim,Stephen Linda J.,D’Souza Wendyl,Cappucci Sheri,McMurray Rob,Sainz-Fuertes Ricardo,Villanueva Vicente

Funder

Eisai Inc

Publisher

Elsevier BV

Reference38 articles.

1. Perampanel improves cortical myoclonus and disability in progressive myoclonic epilepsies: a case series and a systematic review of the literature;Assenza;Front. Neurol.,2021

2. Efficacy and tolerability of perampanel in a patient with Late-Onset myoclonic epilepsy in Down syndrome (LOMEDS): a case report;Corniello;Neurol. Sci.,2023

3. Open-label, uncontrolled retrospective study of perampanel in adults with Lennox-Gastaut syndrome;Crespel;Seizure,2020

4. Next generation sequencing methods for diagnosis of epilepsy syndromes;Dunn;Front. Genet.,2018

5. Eisai Inc., Fycompa® (perampanel) Prescribing Information, 2021. Available at: 〈https://www.fycompa.com/media/media/Files/Fycompa/Fycompa_Prescribing_Information.pdf〉.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review;Expert Review of Neurotherapeutics;2024-08-19

2. Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study;Neurology and Therapy;2024-04-28